Skip to content
To the full analysis

Vitrolife stock: balance sheet and debt

VITR.ST
$11.81Closing price of 12 Nov 2026MEQIRI Score 51 out of 100

Vitrolife has a debt to equity ratio of 0.2.

Daily figure as of 13 Nov 2026

Debt / Equity
0.2
Interest coverage
−50x
Current ratio
3.4
Cash & equivalents
$81.12M
Total assets
$1.12B
Equity ratio
71%
Goodwill
$445.51M
Plus intangible assets of $384.54M
Net debt
$79.82M

Total assets and equity ratio

How large the balance sheet of Vitrolife AB (publ) is, how much of it is equity and how much is goodwill from acquisitions.

Equity ratio

Figures as a table
YearTotal assetsGoodwill and intangible assetsof which goodwillEquity ratioNet debt
2006$27.18M$10.82M$8.35M81.4%−$1.45M
2007$30.03M$10.76M$8.35M84.6%−$1.86M
2008$34.36Mnot reported separatelynot reported separately85.3%−$749.13K
2009$36.03M$13.22M$9.76M86.9%−$582.88K
2010$43.06M$18.61M$12.06M76.0%$3.37M
2011$46.8M$20.5M$12.11M73.7%$4.62M
2012$46.35M$21.66M$18.26M60.4%$6.35M
2013$48.91M$20.68M$18.38M66.1%−$1.52M
2014$97.51M$56.29M$36.55M72.2%−$2.19M
2015$106.21M$51.69M$35.14M79.8%−$15.25M
2016$125.39M$65.08M$40.43M81.6%−$15.18M
2017$142.63M$60.94M$41M86.4%−$39.66M
2018$170.21M$73M$42.28M88.1%−$49.21M
2019$214.45M$78.04M$42.7M84.1%−$61.54M
2020$231.13M$70.46M$40.43M87.5%−$91.36M
2021$1.95B$1.76B$1.3B79.0%$185.74M
2022$2.06B$1.86B$1.39B81.5%$165.15M
2023$1.64B$1.39B$961.7M77.9%$123.13M
2024$1.75B$1.45B$1.01B78.2%$95.66M
2025$1.12B$830.05M$445.51M71.0%$79.82M

The equity ratio divides total equity, including non-controlling interests, by total assets. Net debt is debt minus cash and short-term investments; a negative figure means cash exceeds debt.

Equity and debt

What the company owns and owes

  • Cash & equivalents
  • Equity
  • Debt
Figures as a table
YearCash & equivalentsEquityDebtDebt / Equity
2006$1.45M$22.12M$00
2007$1.86M$25.41M$00
2008$1.4M$29.29M$655.57K0.02
2009$1.6M$31.24M$1.02M0.03
2010$1.87M$32.66M$5.23M0.16
2011$2.09M$34.39M$6.72M0.19
2012$1.17M$27.85M$7.53M0.27
2013$5.39M$32.18M$3.88M0.12
2014$10.79M$70.28M$8.6M0.12
2015$20.01M$84.54M$4.76M0.06
2016$18.98M$102.08M$3.8M0.04
2017$39.7M$122.92M$48.13K0
2018$49.21M$149.7M$00
2019$69.14M$179.89M$7.61M0.04
2020$97.62M$201.8M$6.26M0.03
2021$63.18M$1.54B$248.92M0.16
2022$57.96M$1.68B$223.1M0.13
2023$86.33M$1.28B$209.47M0.16
2024$113.81M$1.37B$209.47M0.15
2025$81.12M$791.54M$160.94M0.2

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Currency
Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = SEK 9.9729)
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 3 Nov 2026)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy